- Home
- COYA vs SVII Comparison
COYA vs SVII Comparison
Compare COYA & SVII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COYA
- SVII
- Stock Information
- Founded
- COYA 2020
- SVII 2021
- Country
- COYA United States
- SVII United States
- Employees
- COYA N/A
- SVII N/A
- Industry
- COYA Biotechnology: Pharmaceutical Preparations
- SVII Blank Checks
- Sector
- COYA Health Care
- SVII Finance
- Exchange
- COYA Nasdaq
- SVII Nasdaq
- Market Cap
- COYA 107.0M
- SVII 119.4M
- IPO Year
- COYA 2022
- SVII 2022
- Fundamental
- Price
- COYA $6.08
- SVII $12.05
- Analyst Decision
- COYA Strong Buy
- SVII
- Analyst Count
- COYA 4
- SVII 0
- Target Price
- COYA $16.50
- SVII N/A
- AVG Volume (30 Days)
- COYA 96.0K
- SVII 24.4K
- Earning Date
- COYA 11-05-2025
- SVII 01-01-0001
- Dividend Yield
- COYA N/A
- SVII N/A
- EPS Growth
- COYA N/A
- SVII N/A
- EPS
- COYA N/A
- SVII 0.17
- Revenue
- COYA $423,452.00
- SVII N/A
- Revenue This Year
- COYA N/A
- SVII N/A
- Revenue Next Year
- COYA N/A
- SVII N/A
- P/E Ratio
- COYA N/A
- SVII $72.70
- Revenue Growth
- COYA N/A
- SVII N/A
- 52 Week Low
- COYA $4.65
- SVII $11.20
- 52 Week High
- COYA $10.24
- SVII $12.74
- Technical
- Relative Strength Index (RSI)
- COYA 45.51
- SVII 51.87
- Support Level
- COYA $6.05
- SVII $11.91
- Resistance Level
- COYA $6.53
- SVII $12.35
- Average True Range (ATR)
- COYA 0.46
- SVII 0.11
- MACD
- COYA -0.05
- SVII -0.01
- Stochastic Oscillator
- COYA 12.69
- SVII 31.84
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
About SVII Spring Valley Acquisition Corp. II
Spring Valley Acquisition Corp II is a blank check company.